Therapeutic agents have been associated with cellular toxicity of both the male and female reproductive systems. Fertility biomarkers that can provide a comprehensive profile of the state of reproductive health, toxic damage, and endocrine function are critically important to research, drug development, and improving clinical care. Key biomarkers–such as luteinizing hormone (LH), follicle stimulating hormone (FSH), progesterone, and estradiol—are of particular interest to the fertility research community.
MSD provides solutions to support and simplify your fertility research needs. We offer assays to measure fertility biomarkers such as FSH and prolactin.